Abstract:Background The pandemic of coronavirus disease 2019 (COVID-19) has become the first concern in international affairs as the novel coronavirus (SARS-CoV-2) is spreading all over the world at a terrific speed. The accuracy of early diagnosis is critical in the control of the spread of the virus. Although the real-time RT-PCR detection of the virus nucleic acid is the current golden diagnostic standard, it has high false negative rate when only apply single test. Objective Summarize the baseline characteristics and laboratory examination results of hospitalized COVID-19 patients. Analyze the factors that could interfere with the early diagnosis quantitatively to support the timely confirmation of the disease. Methods All suspected patients with COVID-19 were included in our study until Feb 9th, 2020. The last day of follow-up was Mar 20th, 2020. Throat swab real-time RT-PCR test was used to confirm SARS-CoV-2 infection. The difference between the epidemiological profile and first laboratory examination results of COVID-19 patients and non-COVID-19 patients were compared and analyzed by multiple logistic regression. Receiver operating characteristic (ROC) curve and area under curve (AUC) were used to assess the potential diagnostic value in factors, which had statistical differences in regression analysis. Results In total, 315 hospitalized patients were included. Among them, 108 were confirmed as COVID-19 patients and 207 were non-COVID-19 patients. Two groups of patients have significance in comparing age, contact history, leukocyte count, lymphocyte count, C-reactive protein, erythrocyte sedimentation rate (p<0.10). Multiple logistic regression analysis showed age, contact history and decreasing lymphocyte count could be used as individual factor that has diagnostic value (p<0.05). The AUC of first RT-PCR test was 0.84 (95% CI 0.73-0.89), AUC of cumulative two times of RT-PCR tests was 0.92 (95% CI 0.88-0.96) and 0.96 (95% CI 0.93-0.99) for cumulative three times of RT-PCR tests. Ninety-six patients showed typical pneumonia radiological features in first CT scan, AUC was 0.74 (95% CI 0.60-0.73). The AUC of patients age, contact history with confirmed people and the decreased lymphocytes were 0.66 (95% CI 0.60-0.73), 0.67 (95% CI 0.61-0.73), 0.62 (95% CI 0.56-0.69), respectively. Taking chest CT scan diagnosis together with patients age and decreasing lymphocytes, AUC would be 0.86 (95% CI 0.82-0.90). The age threshold to predict COVID-19 was 41.5 years, with a diagnostic sensitivity of 0.70 (95% CI 0.61-0.79) and a specificity of 0.59 (95% CI 0.52-0.66). Positive and negative likelihood ratios were 1.71 and 0.50, respectively. Threshold of lymphocyte count to diagnose COVID-19 was 1.53x109/L, with a diagnostic sensitivity of 0.82 (95% CI 0.73-0.88) and a specificity of 0.50 (95% CI 0.43-0.57). Positive and negative likelihood ratios were 1.64 and 0.37, respectively. Conclusion Single RT-PCR test has relatively high false negative rate. When first RT-PCR test show negative result in suspected patients, the chest CT scan, contact history, age and lymphocyte count should be used combinedly to assess the possibility of SARS-CoV-2 infection.

Reasons and Solutions for "false Positive Results" of 2019 Novel Coronavirus-Specific Antibodies Detection

Analysis of factors associated early diagnosis in coronavirus disease 2019 (COVID-19)

Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection kits and strategy to reduce false negative

Negative results in nucleic acid test of COVID-19 patients: assessment from the perspective of clinical laboratories

Evaluating the Value of Anti-SARS-CoV-2 Antibody-Based Tests for COVID-19 Diagnosis

False-positive Results of Gold Immunochromatography Assay for IgM and IgG Antibodies to 2019-Ncov

Diagnostic Options for Coronavirus Disease 2019 (COVID-19).

Analysis of the diagnostic value of serum specific antibody testing for coronavirus disease 2019

False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives

Laboratory diagnosis of COVID-19 in China: A review of challenging cases and analysis

Recent progress on the diagnosis of 2019 Novel Coronavirus

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

Clinical Applications of Detecting IgG, IgM or IgA Antibody for the Diagnosis of COVID-19: A Meta-Analysis and Systematic Review.

Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019

A preliminary study on analytical performance of serological assay for SARS-CoV-2 IgM/IgG and application in clinical practice

Evaluating the value of anti-SARS-CoV-2 antibody detection and neutralizing responses with euvirus: a population of 10776 close contacts in the epidemic of Fujian

Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases

False-positive Colloidal Gold-Based Immunochromatographic Strip Assay Reactions for Antibodies to SARS-CoV-2 in Patients with Autoimmune Diseases

The comparative superiority of IgM-IgG antibody test to real-time reverse transcriptase PCR detection for SARS-CoV-2 infection diagnosis

Research progress in laboratory detection of SARS-CoV-2

Clinical Significance of an IgM and IgG Test for Diagnosis of Highly Suspected COVID-19